1-甲基-1H-吡咯并[2,3-b]吡啶-3-羧酸
|
M174948-250mg
|
≥97% |
171919-37-2 |
250mg
|
¥ 120.9
|
现货 |
阿拉丁 |
Crosstide
|
C348289-5mg
|
≥95% |
171783-05-4 |
5mg
|
¥ 3670.9
|
现货 |
阿拉丁 |
Crosstide
|
C348289-25mg
|
≥95% |
171783-05-4 |
25mg
|
¥ 12976.9
|
现货 |
阿拉丁 |
ANP-Linker
|
A335951-250mg
|
≥99%(HPLC) |
171778-06-6 |
250mg
|
¥ 92.9
|
现货 |
阿拉丁 |
双(氟磺酰)亚胺锂
|
L157764-500g
|
≥98%(T) |
171611-11-3 |
500g
|
¥ 699.9
|
现货 |
阿拉丁 |
3-甲基异唑-4-羧酸
|
M123592-5g
|
≥98% |
17153-20-7 |
5g
|
¥ 824.9
|
现货 |
阿拉丁 |
3-甲基异唑-4-羧酸
|
M123592-25g
|
≥98% |
17153-20-7 |
25g
|
¥ 3536.9
|
现货 |
阿拉丁 |
3-乙基-5-甲基异噁唑-4-羧酸
|
E167863-250mg
|
≥97% |
17147-85-2 |
250mg
|
¥ 82.9
|
现货 |
阿拉丁 |
CM 4620
|
C413652-50mg
|
Moligand™, ≥99% |
1713240-67-5 |
50mg
|
¥ 2128.9
|
现货 |
阿拉丁 |
CM 4620
|
C413652-10mg
|
Moligand™, ≥99% |
1713240-67-5 |
10mg
|
¥ 782.9
|
现货 |
阿拉丁 |
硝酸异丙酯
|
I342774-25g
|
≥98% |
1712-64-7 |
25g
|
¥ 734.9
|
现货 |
阿拉丁 |
硝酸异丙酯
|
I342774-100g
|
≥98% |
1712-64-7 |
100g
|
¥ 2310.9
|
现货 |
阿拉丁 |
六氟钛酸钠(IV)
|
S283267-500g
|
≥98% |
17116-13-1 |
500g
|
¥ 401.9
|
现货 |
阿拉丁 |
六氟钛酸钠(IV)
|
S283267-2.5kg
|
≥98% |
17116-13-1 |
2.5kg
|
¥ 1185.9
|
现货 |
阿拉丁 |
六氟钛酸钠(IV)
|
S283267-100g
|
≥98% |
17116-13-1 |
100g
|
¥ 106.9
|
现货 |
阿拉丁 |
3-碘苯甲酰氯
|
I157680-25g
|
≥98%(GC) |
1711-10-0 |
25g
|
¥ 708.9
|
现货 |
阿拉丁 |
3-碘苯甲酰氯
|
I157680-100g
|
≥98%(GC) |
1711-10-0 |
100g
|
¥ 2535.9
|
现货 |
阿拉丁 |
5-乙酰基-2,4-二甲基-1H-吡咯-3-羧酸
|
A167857-5g
|
≥95% |
17106-15-9 |
5g
|
¥ 3336.9
|
现货 |
阿拉丁 |
5-乙酰基-2,4-二甲基-1H-吡咯-3-羧酸
|
A167857-250mg
|
≥95% |
17106-15-9 |
250mg
|
¥ 331.9
|
现货 |
阿拉丁 |
9,9-二丁基-8-(二氟亚甲基)-2,5,7-三恶唑-9-锡烷十三烷
|
D182034-50mg
|
≥95% |
170941-63-6 |
50mg
|
¥ 858.9
|
现货 |
阿拉丁 |
9,9-二丁基-8-(二氟亚甲基)-2,5,7-三恶唑-9-锡烷十三烷
|
D182034-250mg
|
≥95% |
170941-63-6 |
250mg
|
¥ 2904.9
|
现货 |
阿拉丁 |
Fisogatinib (BLU-554)
|
F414033-50mg
|
Moligand™, ≥98% |
1707289-21-1 |
50mg
|
¥ 825.9
|
现货 |
阿拉丁 |
Fisogatinib (BLU-554)
|
F414033-25mg
|
Moligand™, ≥98% |
1707289-21-1 |
25mg
|
¥ 714.9
|
现货 |
阿拉丁 |
Fisogatinib (BLU-554)
|
F414033-1mg
|
Moligand™, ≥98% |
1707289-21-1 |
1mg
|
¥ 333.9
|
现货 |
阿拉丁 |